Friday, October 04, 2024 12:14:30 PM
mani,
😶
The completed P3, P3 independent peer review, and the other two peer reviews below are quite recent. Additionally, the emerging combo data are only recently beginning to come to light, and the whole idea of combining PD-1 with DC vaccines is a relatively new idea.
As a point of reference, PD-1 technology has only been commercialized for 10 years.
Being acquired “at a much earlier stage” is not necessarily a good thing—the price that any company would pay is lower before efficacy is validated or before regulators approve a new technology.
https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847
https://www.nature.com/articles/s41467-024-48073-y
https://thejns.org/caselessons/downloadpdf/view/journals/j-neurosurg-case-lessons/8/2/article-CASE24112.pdf
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175182311
😶
The completed P3, P3 independent peer review, and the other two peer reviews below are quite recent. Additionally, the emerging combo data are only recently beginning to come to light, and the whole idea of combining PD-1 with DC vaccines is a relatively new idea.
As a point of reference, PD-1 technology has only been commercialized for 10 years.
Being acquired “at a much earlier stage” is not necessarily a good thing—the price that any company would pay is lower before efficacy is validated or before regulators approve a new technology.
https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847
https://www.nature.com/articles/s41467-024-48073-y
https://thejns.org/caselessons/downloadpdf/view/journals/j-neurosurg-case-lessons/8/2/article-CASE24112.pdf
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175182311
Bullish
Believe carefully. This is the greatest and most powerful lesson that I have learned since arriving on Earth. Examine what you believe about yourself most importantly, and then believe carefully as you interact with the world.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
